- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- Finland / Suomi
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
CHEONGJU, South Korea: South Korea’s Ministry of Food and Drug Safety has issued a re-approval of the health claim that consumers from 3 to 80 years old of the sweetener XIVIA Xylitol have a reduced risk of dental caries. The manufacturer, DuPont Nutrition & Health, is the first company in the country to receive such re-approval.
In the re-evaluation of the sweetener, the ministry reviewed 146 research reports, including 94 clinical trials, and concluded that XIVIA Xylitol helps reduce the risk of caries at an effective daily dosage adjusted from 10–25 g down to 5–10 g, a similar amount to that of international dental association standards.
In South Korea, functional ingredients that have received a health claim approval undergo a mandatory re-evaluation every ten years. With the latest re-approval, DuPont Nutrition & Health continues to work with manufacturers to create sugar-free products with oral health in mind.
XIVIA Xylitol is claimed to deliver sweetness at 50 per cent of the calorie level of sugar. In addition, it is preferred for its relatively low glycaemic index, which makes it suitable for diabetic and health-conscious consumers. In addition to replacing sugar in chewing gum and other confectionery applications, xylitol is commonly incorporated into oral hygiene products, including toothpaste, mouthwash and teething gels.
Thu. 4 April 2024
4:00 pm EST (New York)
Reimagining success with ClearCorrect: From case planning to practice growth
Tue. 9 April 2024
1:00 pm EST (New York)
Soluzioni innovative per sostenere l’evoluzione dello studio: Lo strumento giusto può fare la differenza
Tue. 9 April 2024
7:00 pm EST (New York)
ITI US section live treatment planning session
Wed. 10 April 2024
5:00 am EST (New York)
A tooth is extracted—what now? Is there any benefit to ridge augmentation?
Wed. 10 April 2024
8:00 pm EST (New York)
Santa Fe Group Medicare Update
Thu. 11 April 2024
3:30 am EST (New York)
Por qué implementar Invisalign Go en tu consulta?
Mon. 15 April 2024
4:00 pm EST (New York)
To post a reply please login or register